Culture at high density improves the ability of human macrophages to control mycobacterial growth
- PMID: 11342642
- DOI: 10.4049/jimmunol.166.10.6203
Culture at high density improves the ability of human macrophages to control mycobacterial growth
Abstract
The mechanisms through which granuloma formation helps control mycobacterial infection are poorly understood, but it is possible that the accumulation of macrophages at high density at sites of infection promotes the differentiation of macrophages into cells with improved mycobactericidal activity. To test this possibility, varying numbers of monocytes were cultured in 96-well plates for 3 days, infected with Mycobacterium bovis bacillus Calmette-Guérin, and mycobacterial number was assessed 7 days after infection based on the measurement of luciferase activity expressed by a mycobacterial reporter strain or by counting CFU. Mycobacterial growth was optimal in cultures containing 5 x 10(4) cells/well, but increasing the number of cells to 2 x 10(5) cells/well resulted in complete inhibition of mycobacterial growth. This effect could not be explained by differences in mycobacterial uptake, multiplicity of infection, acidification of the extracellular medium in high density cultures, enhanced NO production, or paracrine stimulation resulting from secretion of cytokines or other proteins. The morphology of cells cultured at high density was strikingly different from that of monocytes cultured at 5 x 10(4) cells/well, including the appearance of numerous giant cells. The bacteriostatic activity of monocyte-derived macrophages was also dependent on cell number, but fewer of these more mature cells were required to control mycobacterial growth. Thus, the ability of human macrophages to control mycobacterial infection in vitro is influenced by the density of cells present, findings that may help explain why the formation of granulomas in vivo appears to be a key event in the control of mycobacterial infections.
Similar articles
-
Effect of stimulation of human macrophages on intracellular survival of Mycobacterium bovis Bacillus Calmette-Guerin. Evaluation with a mycobacterial reporter strain.Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1629-37. doi: 10.1164/ajrccm.159.5.9807021. Am J Respir Crit Care Med. 1999. PMID: 10228137
-
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.J Immunol. 2001 Jun 1;166(11):6728-34. doi: 10.4049/jimmunol.166.11.6728. J Immunol. 2001. PMID: 11359829
-
Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG.Infect Immun. 2002 Jun;70(6):3020-5. doi: 10.1128/IAI.70.6.3020-3025.2002. Infect Immun. 2002. PMID: 12010993 Free PMC article.
-
The effect of NG-monomethyl-L-arginine(LNMMA), an NO-synthase blocker on the survival of intracellular BCG within human monocyte-derived macrophages.Biochem Mol Biol Int. 1996 Nov;40(5):1033-46. doi: 10.1080/15216549600201673. Biochem Mol Biol Int. 1996. PMID: 8955894
-
Effects of diesel particles on the control of intracellular mycobacterial growth by human macrophages in vitro.FEMS Immunol Med Microbiol. 2006 Apr;46(3):419-25. doi: 10.1111/j.1574-695X.2006.00050.x. FEMS Immunol Med Microbiol. 2006. PMID: 16553816
Cited by
-
Quorum sensing in the immune system.Nat Rev Immunol. 2018 Sep;18(9):537-538. doi: 10.1038/s41577-018-0040-4. Nat Rev Immunol. 2018. PMID: 30006523 Free PMC article.
-
Live-cell imaging reveals single-cell and population-level infection strategies of Listeria monocytogenes in macrophages.Front Immunol. 2023 Aug 22;14:1235675. doi: 10.3389/fimmu.2023.1235675. eCollection 2023. Front Immunol. 2023. PMID: 37675103 Free PMC article.
-
Macro- and micro-scale culture environment differentially regulate the effects of crowding on macrophage function.Biotechnol Bioeng. 2024 Jan;121(1):306-316. doi: 10.1002/bit.28554. Epub 2023 Oct 4. Biotechnol Bioeng. 2024. PMID: 37792882 Free PMC article.
-
TREM-1 Is Upregulated in Experimental Periodontitis, and Its Blockade Inhibits IL-17A and RANKL Expression and Suppresses Bone loss.J Clin Med. 2019 Oct 1;8(10):1579. doi: 10.3390/jcm8101579. J Clin Med. 2019. PMID: 31581596 Free PMC article.
-
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5. doi: 10.1073/pnas.0400983101. Epub 2004 Mar 19. Proc Natl Acad Sci U S A. 2004. PMID: 15070757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources